Evidence map›Paper›PMID 21457735›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2011

Biomaterials to gene delivery.

Sung Wan Kim

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Functional polymers of gene delivery for treatment of myocardial infarct.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sung Wan KimDepartment of Pharmaceutics, Pharmaceutical Chemistry, University of Utah, 20 South 2030 East, Salt Lake City, Utah 84112-5820, United States.

Funding

FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERSR01HL065477 · NHLBI · UNIVERSITY OF UTAH · PI KIM, SUNG WAN · 2000 to 2012
$4.3M
RGD-POLYMER TARGETING PLASMID TO ANGIOGENIC ENDOTHELIUMR01CA107070 · NCI · UNIVERSITY OF UTAH · PI KIM, SUNG WAN · 2004 to 2013
$2.7M
MODIFIED POLY(DISULFIDE AMINE)AS A PANCREAS TARGETING POLYMERIC VECTORR01DK085075 · NIDDK · UNIVERSITY OF UTAH · PI KIM, SUNG WAN · 2010 to 2014
$1.4M
REDUCIBLE POLYAMIDO ETHYLENIMINE FOR GLP-1 PLASMID DELIVERYR01DK077703 · NIDDK · UNIVERSITY OF UTAH · PI KIM, SUNG WAN · 2008 to 2012
$1.3M
NCI NIH HHS CA107070NCI NIH HHS R01 CA107070NHLBI NIH HHS HL056477NHLBI NIH HHS R01 HL065477NIDDK NIH HHS DK077703NIDDK NIH HHS DK085075NIDDK NIH HHS R01 DK077703NIDDK NIH HHS R01 DK085075
6 · The paper itself

Abstract

It has been over 40 years since I started biomaterials research. This article is a short summary of past research in my laboratory.

Indexed as

Gene Transfer TechniquesAnimalsBiocompatible MaterialsDrug CarriersHumansPolymersBiocompatible MaterialsDrug CarriersPolymers

Identifiers

PMID21457735
PMCPMC4603657

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.